Niven Narain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BPGbio, Inc : BPGbio Brings Late Clinical Stage Rare Disease and Oncology Assets to US and EU Pharma Partnering Summits

BPGbio, Inc : BPGbio Brings Late Clinical Stage Rare Disease and Oncology Assets to US and EU Pharma Partnering Summits
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Oak ridgeUnited statesSan diegoNiven narainDaniel elliottBpgbio incOak ridge national laboratoryPartnering summitBoard memberChief commercial advisorOrphan drugInterrogative biologyInterrogative biology platformCarsten stork

AACR Annual Meeting 2024: The key announcements you need to read

Last week (April 5), the American Association for Cancer Research (AACR) welcomed the industry to the San Diego Convention Center for the AACR Annual Meeting 2024.

United statesNader sanaiLaura dillionHeidelberg pharmaBonnie phillipsNiven narainYanchao wangJonathan kaufmanIvy brain tumor centerUniversity of tennesseeIvy centerOak ridge national laboratoryStanford universityEmory university school of medicinePharma reporterBrain tumor center

BPGbio Working with US DoD on AI-Based Prostate, Breast Cancer Dx

The company is building off a previous partnership with the agency related to prostate cancer to analyze samples for breast cancer.

United statesMichael kiebishNiven narainJoseph caravalhoUs department of defenseVeterans affairs northern california health care systemWindber research instituteProstate health diagnostic panelInterrogative biologyCell deathAfrican americanScientific reportsLatin americaClinical breast care projectUniformed services universityHealth sciences

BPGBio partners with skin disease association to progress drug development

Finding a treatment for a skin disease that significantly diminishes the quality of life for those living with it has moved forward to the next phase of trials.

United statesNiven narainRobert kirsnerBrett kopelanUniversity of miami miller school medicineBpgbio incEpidermolysis bullosaMiami miller schoolInterrogative biologyplatformClinical developmentPreclinical researchDrug deliveryMergers and acquisitionsAtient centricityLinical evolutionPis active pharmaceutical ingredients

BPGBio partners with skin disease association to progress drug development

Finding a treatment for a skin disease that significantly diminishes the quality of life for those living with it has moved forward to the next phase of trials.

United statesBrett kopelanNiven narainRobert kirsnerUniversity of miami miller school medicineBpgbio incEpidermolysis bullosaMiami miller schoolInterrogative biologyplatformClinical developmentPreclinical researchDrug deliveryMergers and acquisitionsAtient centricityLinical evolutionPis active pharmaceutical ingredients